See the DrugPatentWatch profile for forteo
How Forteo Affects Calcium Levels
Forteo (teriparatide) is a synthetic parathyroid hormone used to treat osteoporosis by stimulating bone formation. It increases serum calcium levels in most patients, typically within the first few hours after dosing, peaking around 4-6 hours and returning to baseline by 16-24 hours.[1][2] This transient hypercalcemia occurs because teriparatide mimics PTH, which mobilizes calcium from bones and enhances kidney reabsorption.
Common Calcium-Related Side Effects
- Hypercalcemia: Seen in 1-11% of patients, usually mild and asymptomatic. Levels rarely exceed 12 mg/dL but require monitoring, especially in early treatment.[1][3]
- Hypercalciuria: Increased urinary calcium excretion affects up to 20% of users, raising kidney stone risk if not managed.[2]
These effects are dose-dependent and more common with the full 20 mcg daily subcutaneous dose.
Monitoring and Management
Doctors check serum calcium 4-6 hours post-dose periodically during the first 2 months, then monthly if elevated. Hold dosing if calcium >9.2 mg/dL pre-dose or >10.6 mg/dL post-dose; resume at reduced frequency once normalized. Ensure adequate hydration and avoid thiazide diuretics, which can worsen hypercalcemia.[1][3]
Risks if Calcium Levels Stay High
Persistent elevations (>11 mg/dL) can lead to nausea, vomiting, constipation, fatigue, or confusion. Long-term, it heightens risks of kidney stones, nephrocalcinosis, or arrhythmias in those with heart conditions. Pre-existing hypercalcemia or hyperparathyroidism contraindicates Forteo use.[2]
Who Gets Hit Hardest
Effects are more pronounced in patients with renal impairment (CrCl <30 mL/min), vitamin D deficiency, or concurrent calcium/vitamin D supplements. Elderly patients or those on loop diuretics may see amplified changes.[1][3]
[1]: Forteo Prescribing Information (FDA)
[2]: Forteo Summary of Product Characteristics (EMA)
[3]: Medscape - Teriparatide Side Effects